Evolving resistance patterns in community-acquired respiratory tract pathogens: First results from the PROTEKT global surveillance study

Journal of Infection

Volumn 44, Issue SUPPL. A, 2002, Pages 3-10

  Felmingham, D ^a  

^a GR Micro Ltd   (United Kingdom)

Author keywords

Ketolide; PROTEKT; Resistance; Respiratory tract infection; Surveillance; Telithromycin

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFDITOREN; CEFIXIME; CEFPODOXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; ERYTHROMYCIN; KETOLIDE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINUPRISTIN; TEICOPLANIN; TELITHROMYCIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG DISTRIBUTION; DRUG SURVEILLANCE PROGRAM; GENOTYPE; HAEMOPHILUS INFLUENZAE; HUMAN; IC 50; MORAXELLA CATARRHALIS; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRESCRIPTION; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; GENETICS; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTIBIOTICS, MACROLIDE; BETA-LACTAM RESISTANCE; COMMUNITY-ACQUIRED INFECTIONS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; ANTI-BACTERIAL AGENTS; KETOLIDES; MACROLIDES;

EID: 0036265885     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Epidemiology and treatment of chronic bronchitis and its exacerbations
2. Community-acquired pneumonia. Etiology, epidemiology and treatment
3. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
4. The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral bacterial agents against respiratory pathogens
5. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases
6. Community-acquired pneumonia: Epidemiology, etiology, treatment
7. Prospective study of community-acquired pneumonia of bacterial etiology in adults
8. Antibiotic resistance. Do we need new therapeutic approaches?
9. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
10. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents
11. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
12. B resistance induction by the ketolide telithromycin (HMR 3647): Role of the 3-keto group
13. Emergence of antibiotic resistance in upper and lower respiratory tract infections
14. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an efflux system
15. Prevalence and characterisation of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
16. Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens